AlphaFold predicted structure
HAAO · P46952

Mean pLDDT
95.8/ 100
Very high
286 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)7%
- Low(50–70)1%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
3-hydroxyanthranilate 3,4-dioxygenase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
CAKUT
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalUnexplained young onset end-stage renal disease - additional genes
BIALLELIC, autosomal or pseudoautosomalVACTERL-like phenotypes
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
vertebral, cardiac, renal, and limb defects syndrome 1
congenital vertebral-cardiac-renal anomalies syndrome
hypertensive disorder
prostate carcinoma
hypospadias
benign prostatic hyperplasia
Increased blood pressure
cardiovascular disorder
cerebral small vessel disease
bone fracture
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
3-hydroxyanthranilate 3,4-dioxygenase
Catalyzes the oxidative ring opening of 3-hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde, which spontaneously cyclizes to quinolinate
HAAO · P46952

Mean pLDDT
95.8/ 100
Very high
286 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0